Literature DB >> 25105184

FDA approves Dalvance to treat skin infections.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25105184

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  New agents approved for treatment of acute staphylococcal skin infections.

Authors:  Jan Tatarkiewicz; Anna Staniszewska; Magdalena Bujalska-Zadrożny
Journal:  Arch Med Sci       Date:  2016-05-11       Impact factor: 3.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.